Navigation Links
Surgery for early stage prostate cancer is better than waiting

In a research report done by Swedish scientists its said that it is better// to go for surgery while in early stage of prostate cancer than to wait and see if the disease progresses.

Surgery for treating prostate cancer, also known as prostatectomy, is a common procedure. The researchers had conducted he study to see if prostatectomy done in early stages of prostate cancer benefits the patients more than watching and waiting the cancer in the prostate gland to develop before going for the surgery.

Researchers are of the opinion that watching the patient in the early stages of prostate cancer and waiting for it to spread before conducting prostatectomy may not be much beneficial to the patients in terms of mortality and disease being spread to other parts of the body.

The results of the study, reported in the latest edition of New England Journal of Medicine, suggests that prostatectomy done in the early stages of cancer increases the rate of survival of the patients below 65 years of age by 40%. The rate of spread of cancer from the target cells to other locations, also known as metastasis, gets reduced by 44% when surgery is performed early. Although after a follow up period of ten years, early prostatectomy does not seem to be much beneficial in reducing the rate of mortality by a big margin, this procedure is substantially more advantageous in reducing the spread of the disease. , prostatectomy, prostate cancer, metastasis, rate of mortality, early stage, rate of survival
'"/>




Page: 1

Related medicine news :

1. Bypass Heart Surgery Performed Without General Anesthesia
2. Indian Prime Minister has successful Knee Replacement Surgery
3. Surgery made simple
4. Surgery a safety in senility
5. Breast Cancer Surgery Causes Psychological problems
6. Radiofrequency Energy Cooks Tumors Without Surgery
7. Heart Surgery Is Getting Safer for the Old
8. Surgery-Rigged pulley helps patients
9. Blood Vessel Surgery Safe for Diabetics
10. Ulcer Surgery connected to danger of Pancreatic Cancer
11. Surgery beneficial in Menieres disease
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/28/2017)... ... March 28, 2017 , ... Medforce Technologies, Inc., ... to announce it has joined the National Association for Home Care and Hospice ... ill, disabled, and dying Americans of all ages and the caregiver who provide ...
(Date:3/28/2017)... ... March 28, 2017 , ... Alert Sentry Group LLC., ... (Mobile Personal Emergency Response Systems), the iSAFE and the iSAFE Plus. These iSAFE products ... first of their kind, the iSAFE and iSAFE Plus offer direct GPS Location and ...
(Date:3/28/2017)... ... March 28, 2017 , ... Usually, the impending arrival ... wardrobe. However, for those self-conscious about a double chin, this means more anxiety than ... solution. , “For most people, a double chin is undesirable,” Dr. Goldman said, ...
(Date:3/28/2017)... (PRWEB) , ... March 28, 2017 , ... ... leading physicians, Paul Yost, will begin serving as new board chair for Orange ... month. Yost will serve the remainder of soon-to-be former chair Mark Refowitz’s term, ...
(Date:3/28/2017)... ... , ... With less than 10,000 dermatologists in the United States and more ... while the desire to conquer breakouts and eliminate skincare stress is widespread. Curology ... today released its inaugural survey on the State of Acne in America. , ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... , March 28, 2017 The ... reach USD 8.0 billion by 2025, according to a ... incidence of infectious diseases and cancer is expected to ... disease diagnosis over the coming years. In addition, higher ... autologous and allogenic stem cell therapy, due to adverse ...
(Date:3/27/2017)... 27, 2017 Summary This ... Bayer and its partnering interests and activities since 2010. ... an in-depth insight into the partnering activity of one of ... company reports are prepared upon purchase to ensure inclusion of ... The report will be delivered in PDF format within ...
(Date:3/27/2017)... , March 27, 2017  ImMAGE Biotherapeutics (OTCMKTS: IMMG), ... successfully passed early toxicology and efficacy studies. The company ... target a specific protein, MAGE A, in an effort ... cancer. After 4 weeks of treatment ... show very little toxicity in a full toxicology report ...
Breaking Medicine Technology: